Infinimmune
Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system.
Last updated on
About Infinimmune
Founded
2022Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$12MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
87NAICs Code
54Location
City
AlamedaState
CaliforniaCountry
United StatesInfinimmune
Find your buyer within Infinimmune
Tech Stack (28)
